<DOC>
	<DOCNO>NCT00990951</DOCNO>
	<brief_summary>The purpose study evaluate efficacy association Senna alexandrina Mill ( sena ) , Cassia fistula L. , Tamarindus indica L. , Coriandrum sativum L. , Periandra mediterranea Taub . patient functional constipation .</brief_summary>
	<brief_title>Study Efficacy Association Senna Alexandrina Mill Associations Functional Intestinal Constipation</brief_title>
	<detailed_description>This phase III trial , placebo-controlled parallel-group design .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Senna Extract</mesh_term>
	<mesh_term>Sennoside A &amp; B</mesh_term>
	<criteria>Patients 1865 year functional constipation ROME IIII criterion In opinion investigator patient adhere protocol Voluntary able understand nature purpose study , include risk adverse effect intent cooperate researcher act accordance requirement entire protocol , confirm signing Consent Informed hypersensitivity component pregnant lactate abdominal pain unknown etiology suspect intestinal occlusion subocclusion suspect abdominal inflammatory condition ( appendicitis , peritonitis , cystitis , endometritis ) Crohn disease colitis Suspected intestinal constipation due abdominal surgery , neurological disorder ( aganglionoses , Parkinson disease , medullar tumor , stroke , multiple sclerosis ) , systemic sclerosis , multiple myeloma , scleroderma Subjects congenital mega colon , anorectal congenital malformation , inflammatory bowel disease intestinal carcinoma history malabsorption diseases history anemia , weight loss anal bleed history hypothyroidism , hyperthyroidism insulindependent diabetes mellitus know positive result human immunodeficiency virus test heart , liver , lung kidney important condition drug alcohol dependence knowledge suspicion malignancy body mass index &lt; 18 body mass index &gt; 30 participation experimental study 12 month prior study familiar history colon carcinoma inflammatory disease Lack adherence procedure protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>